603716 塞力医疗
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)-4.915-12.135-10.371-3.0853.670
总资产报酬率 ROA (%)-1.730-4.344-3.726-1.2071.665
投入资产回报率 ROIC (%)-2.457-6.032-4.957-1.5542.096

边际利润分析
销售毛利率 (%)19.88719.57519.86321.07523.176
营业利润率 (%)-3.534-8.989-6.433-0.6235.502
息税前利润/营业总收入 (%)-0.248-5.963-4.4772.0197.365
净利润/营业总收入 (%)-2.360-7.815-8.241-1.4763.860

收益指标分析
经营活动净收益/利润总额(%)47.91633.2137.248-334.264139.503
价值变动净收益/利润总额(%)94.5981.2353.104106.4560.690
营业外收支净额/利润总额(%)0.2206.32822.52832.797-8.196

偿债能力分析
流动比率 (X)1.6621.7161.6071.8672.109
速动比率 (X)1.4271.4711.3781.6001.820
资产负债率 (%)63.47360.65962.18859.40753.856
带息债务/全部投入资本 (%)50.18944.91248.89250.25446.569
股东权益/带息债务 (%)95.076116.15997.70095.165113.906
股东权益/负债合计 (%)53.72759.73656.97161.24278.318
利息保障倍数 (X)-0.075-1.641-1.1700.6853.230

营运能力分析
应收账款周转天数 (天)272.304295.469274.368226.183225.031
存货周转天数 (天)78.38485.05086.04375.94382.784